Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Achieve Life Sciences Inc ACHV

Healthcare Biotechnology
Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a well-defined, dual-acting mechanism of... see more

Recent & Breaking News (NDAQ:ACHV)

Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update

PR Newswire November 7, 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Benzinga.com  November 4, 2018

10 Hottest Stocks From October 31, 2018

Benzinga.com  October 31, 2018

Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018

PR Newswire October 31, 2018

55 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  October 30, 2018

30 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  October 30, 2018

Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation

PR Newswire October 30, 2018

The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares

Benzinga.com  October 11, 2018

48 Biggest Movers From Yesterday

Benzinga.com  October 2, 2018

38 Stocks Moving In Monday's Mid-Day Session

Benzinga.com  October 1, 2018

Achieve Announces Pricing of $5.6 Million Registered Direct Offering

PR Newswire October 1, 2018

46 Biggest Movers From Friday

Benzinga.com  October 1, 2018

51 Biggest Movers From Yesterday

Benzinga.com  September 28, 2018

Mid-Afternoon Market Update: Bed Bath & Beyond Drops Following Weak Q2 Results; Cameco Shares Surge

Benzinga.com  September 27, 2018

36 Stocks Moving In Thursday's Mid-Day Session

Benzinga.com  September 27, 2018

Mid-Day Market Update: Dow Rises Over 100 Points; Geron Shares Plunge

Benzinga.com  September 27, 2018

Mid-Morning Market Update: Markets Open Higher; Conagra Misses Q1 Views

Benzinga.com  September 27, 2018

30 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  September 27, 2018

Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects

PR Newswire September 27, 2018

Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018

PR Newswire September 26, 2018